- Company home
- Corporate objectives
- Company performance and financials
- Funding and venture capital
- Directors
Company latest
News and press
September 2009
New Product Launch – Ondansetron Oral Liquid…
Focus is pleased to announce the launch of Ondansetron Oral Liquid 4mg per 5ml to the market…
Full storyCorporate objectives
- Focus delivers new niche generic products to the UK market to generate sustainable income streams that can be reinvested in new product development
- Focus aims to maintain its double digit growth through the introduction of at least five new products each year
- Focus dedicates almost half its annual expenditure year on year to developing new generic products for the UK product
- Focus aims to give its customers choices and alternatives in the prescription only medicines market
